-
Diagnostics World Brief | Illumina has announced FDA approval of its Extended RAS Panel for use on the MiSeqDx System. The next-generation sequencing (NGS) kit is intended to help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer with Amgen’s Vectibix (panitumumab).
Jun 30, 2017
-
Diagnostics World Brief | News, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Quest Diagnostics, MDxHealth, QIAGEN, and more.
Jun 29, 2017
-
Diagnostics World Brief | Genoptix and Bionano Genomics today announced an exclusive agreement to co-develop information-rich diagnostics for selected hematologic oncology indications in the US using Bionano’s Saphyr System.
Jun 28, 2017
-
Modern Healthcare | Walmart Stores and Quest Diagnostics announced a partnership Monday that will bring Quest's laboratory testing services to 15 Walmart locations in Florida and Texas by the end of the year.
Jun 27, 2017
-
Diagnostics World Brief | Omar Perez of Pfizer is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include using key commercialization challenges for precision medicine or companion diagnostics, starting the discussion between a diagnostic and a pharmaceutical company regarding co-commercialization, and more.
Jun 27, 2017
-
Diagnostics World Brief | Emulate announced that it has received a research grant to use the company’s human Brain-Chip system and develop a fully automated research platform, to conduct experiments on the International Space Station.
Jun 22, 2017
-
Diagnostics World Brief | Marc Williams of Geisinger Health System is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit. Topics include implementation of NGS in routine car, challenges to overcome, and exciting applications of NGS.
Jun 20, 2017
-
Diagnostics World | The Next Generation Dx Summit will take place August 15-18 in Washington, D. C. Featuring 12 different conference programs covering an array of topics from cancer immunotherapy to point-of-care testing, here are a few highlights for #NGDx17.
Jun 19, 2017
-
Diagnostics World | Allan Haberman’s new report, Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes, discusses the major theme of “second wave” immuno-oncology. He builds on a 2014 Insight Pharma Report which focused on the major classes of cancer immunotherapy drugs that were then emerging from academic and corporate research.
Jun 16, 2017
-
Diagnostics World Brief | Robert Anders of Johns Hopkins Medicine is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit, which runs August 15-18 in Washington, DC. Topics include the integration of genomic, proteomic and immunological markers for cancer immunotherapy, challenges in implementing multiplex approaches, and more.
Jun 14, 2017
-
Diagnostics World Brief | The Faculty Investigator and Director at HudsonAlpha Institute for Biotechnology sits down to discuss her work in whole genome sequencing to diagnose and monitor rare diseases.
Jun 9, 2017
-
STAT |
Proove Biosciences, an Irvine, Calif., firm that purports to determine a patient's likelihood of becoming addicted to opioids, was raided on Wednesday.
Jun 8, 2017